Mohamed M.Y. Kaddah

The dynamic interplay between AMPK/NFκB signaling and NLRP3 is a new therapeutic target in inflammation: Emerging role of dapagliflozin in overcoming lipopolysaccharide-mediated lung injury

Eslam E. Abd El-Fattah, Sameh Saber, Ahmed A.E. Mourad et al. · Biomedicine & Pharmacotherapy · 2022 · 81 citations · Full text

Acute Lung Injury, Inflammatory Lung Disease, Low Dose +22

Empagliflozin adjunct with metformin for the inhibition of hepatocellular carcinoma progression: Emerging approach for new application

A. M. Abdelhamid, Sameh Saber, Mahmoud E. Youssef et al. · Biomedicine & Pharmacotherapy · 2021 · 58 citations · Full text

Albendazole-loaded cubosomes interrupt the ERK1/2-HIF-1α-p300/CREB axis in mice intoxicated with diethylnitrosamine: A new paradigm in drug repurposing for the inhibition of hepatocellular carcinoma progression

Sameh Saber, Mohamed Nasr, Ahmed S. Saad et al. · Biomedicine & Pharmacotherapy · 2021 · 44 citations · Full text

Albendazole-loaded Cubosomes, Nanotherapeutics, Chemoprevention Strategy +20

Coomassie brilliant blue G-250 dye attenuates bleomycin-induced lung fibrosis by regulating the NF-κB and NLRP3 crosstalk: A novel approach for filling an unmet medical need

Mona H. Zohny, Simona Cavalu, Mahmoud E. Youssef et al. · Biomedicine & Pharmacotherapy · 2022 · 40 citations · Full text

Inflammatory Lung Disease, Lung Inflammation, Immunology +18

AKT-AMPKα-mTOR-dependent HIF-1α Activation is a New Therapeutic Target for Cancer Treatment: A Novel Approach to Repositioning the Antidiabetic Drug Sitagliptin for the Management of Hepatocellular Carcinoma

Eslam E. Abd El-Fattah, Sameh Saber, Mahmoud E. Youssef et al. · Frontiers in Pharmacology · 2022 · 26 citations · Full text

Akt-ampkα-mtor-dependent Hif-1α Activation, Stgpt 20, Tumor Biology +18